- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0028462

About Kay Biotech Private Limited
Data last updated:
Kay Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2015PTC281594. Its GSTIN is 07AAFCK8759E1Z7 (Delhi).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sayed Abul Ala and Sayed Shamoon Ahmed.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at First Floor Shop No. – 4 A 5 &6, 1730 Mangal Building Ram Gali Bhagirath Palace, New Delhi, Delhi, India – 110005.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.33 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹6.87 Lakh (net margin 0.3%) and EBITDA of ₹9.66 Lakh (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 48% over five years.
The company is associated with 1 brand: Kaybiotech. As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Kay Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0028462). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kay-biotech.com.
Company details
Recognitions & Rankings of Kay Biotech
Contact details
Kay Biotech Private Limited's registered office is in New Delhi, Delhi. Its website is kay-biotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFirst Floor Shop No. – 4 A 5 &6, 1730 Mangal Building Ram Gali Bhagirath Palace, New Delhi, Delhi, India – 110005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kay Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Kay Biotech operates one associated brand: Kaybiotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online platform selling medicines for various health conditions and treatments. | kaybiotech.co |
Business activity
The main business activity of Kay Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kay Biotech Private Limited, buy the company report.
Financials of Kay Biotech Private Limited
FY 2024 filings availableKay Biotech Private Limited reported revenue of ₹27.33 Cr (up 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 48% over five years, including 11% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kay Biotech Private Limited, buy the company report.
Board of directors of Kay Biotech Private Limited
Kay Biotech has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sayed Abul Ala | Director | 15 Jun 2015 | 11 Years 4 Months | Current |
| Sayed Shamoon Ahmed | Director | 15 Jun 2015 | 11 Years 4 Months | Current |
| Sayed Abu Sualeh | Director | 15 Jun 2015 | 11 Years 4 Months | Current |
Auditor
Kay Biotech Private Limited is audited by MANALI JAIN for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANALI JAIN | FY 2023 | 529816 |
Shareholding
The shareholding of Kay Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kay Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 May 2016 | 100050750 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Kay Biotech Private Limited has 1 court case on record: 1 filed by Kay Biotech. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Commssioner Delhi Goods and Service Tax Department of Trade and Taxes and Anr | Pending |
To see the full case history of Kay Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kay Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kay Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCK8759E1Z7 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kay Biotech Private Limited, buy the company report.
Recent activity
Kay Biotech Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Sayed Abu Sualeh was appointed as Director on 15 Jun 2015.
Frequently asked questions
Kay Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 June 2015 (11+ years old) and is registered under CIN U24233DL2015PTC281594.
Kay Biotech has 3 current directors:
- Sayed Abul Ala - Director
- Sayed Shamoon Ahmed - Director
- Sayed Abu Sualeh - Director
The latest financial statements of Kay Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Kay Biotech is 07AAFCK8759E1Z7, registered in Delhi.
The CIN (Corporate Identification Number) of Kay Biotech is U24233DL2015PTC281594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kay Biotech has 1 court case on record: 1 filed by the company. 1 is pending.
Kay Biotech was incorporated on 15 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Sayed Abu Sualeh was appointed as Director on 15 Jun 2015. Sayed Abul Ala was appointed as Director on 15 Jun 2015. Sayed Shamoon Ahmed was appointed as Director on 15 Jun 2015.
Yes, Kay Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0028462).
Kay Biotech can be reached through the website kay-biotech.com. Its registered office is in New Delhi, Delhi, India.

